New York, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Blood Screening Industry" - https://www.reportlinker.com/p05798062/?utm_source=GNW
4% over the analysis period 2020-2027. Nucleic Acid Test (NAT), one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enzyme-Linked Immunosorbent Assay (ELISA) segment is readjusted to a revised 8.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $611.3 Million, While China is Forecast to Grow at 12.7% CAGR
The Blood Screening market in the U.S. is estimated at US$611.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$910.3 Million by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.
Rapid Tests Segment to Record 9% CAGR
In the global Rapid Tests segment, USA, Canada, Japan, China and Europe will drive the 8.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$256 Million in the year 2020 will reach a projected size of US$449.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$554.3 Million by the year 2027, while Latin America will expand at a 10.6% CAGR through the analysis period. We bring years of research experience to this 9th edition of our report. The 382-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Grifols International SA
- Ortho Clinical Diagnostics, Inc.
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p05798062/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Blood Screening Market to Witness Moderate Growth
The Nucleic Acid Test (NAT) Segment to Register Highest Growth
Global Competitor Market Shares
Blood Screening Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increase in Blood Donation Rates to Bode Well for Market Growth
Percentage of People Preferring to Donate Blood by Select
Countries: 2018
Various Initiatives to Donate Blood Propel Market Growth
Rising Incidence of Infectious Diseases
Total Number of Disease Cases Reported in the US due to
Infected Fleas, Ticks, and Mosquitoes: 2004-2016
Disease Response Towards Climate Change during the Recent Past
Opportunities and Challenges in Blood Screening
Innovations to Propel Market Growth
Various Measures for Ensuring Donated Blood Safety, a Key
Driver for Market Growth
Introduction of Novel Products to Support Market Growth
4. GLOBAL MARKET PERSPECTIVE
Table 1: Blood Screening Global Market Estimates and Forecasts
in US$ Million by Region/Country: 2020-2027
Table 2: Blood Screening Global Retrospective Market Scenario
in US$ Million by Region/Country: 2012-2019
Table 3: Blood Screening Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Nucleic Acid Test (NAT) (Technology) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 5: Nucleic Acid Test (NAT) (Technology) Historic Market
Analysis by Region/Country in US$ Million: 2012 to 2019
Table 6: Nucleic Acid Test (NAT) (Technology) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027
Table 7: Enzyme-Linked Immunosorbent Assay (ELISA) (Technology)
Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Table 8: Enzyme-Linked Immunosorbent Assay (ELISA) (Technology)
Historic Market Perspective by Region/Country in US$ Million:
2012 to 2019
Table 9: Enzyme-Linked Immunosorbent Assay (ELISA) (Technology)
Market Sales Breakdown by Region/Country in Percentage: 2012 VS
2020 VS 2027
Table 10: Rapid Tests (Technology) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027
Table 11: Rapid Tests (Technology) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2012 to 2019
Table 12: Rapid Tests (Technology) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
Table 13: Western Blot Assay (Technology) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2020
to 2027
Table 14: Western Blot Assay (Technology) Market Historic
Review by Region/Country in US$ Million: 2012 to 2019
Table 15: Western Blot Assay (Technology) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027
Table 16: Next-Generation Sequencing (NGS) (Technology) World
Market by Region/Country in US$ Million: 2020 to 2027
Table 17: Next-Generation Sequencing (NGS) (Technology)
Historic Market Analysis by Region/Country in US$ Million: 2012
to 2019
Table 18: Next-Generation Sequencing (NGS) (Technology) Market
Share Distribution in Percentage by Region/Country: 2012 VS
2020 VS 2027
Table 19: Reagents & Kits (Product & Service) World Market
Estimates and Forecasts in US$ Million by Region/Country: 2020
to 2027
Table 20: Reagents & Kits (Product & Service) Market Worldwide
Historic Review by Region/Country in US$ Million: 2012 to 2019
Table 21: Reagents & Kits (Product & Service) Market Percentage
Share Distribution by Region/Country: 2012 VS 2020 VS 2027
Table 22: Instruments (Product & Service) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2020 to
2027
Table 23: Instruments (Product & Service) Global Historic
Demand in US$ Million by Region/Country: 2012 to 2019
Table 24: Instruments (Product & Service) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027
Table 25: Software & Services (Product & Service) World Market
by Region/Country in US$ Million: 2020 to 2027
Table 26: Software & Services (Product & Service) Historic
Market Analysis by Region/Country in US$ Million: 2012 to 2019
Table 27: Software & Services (Product & Service) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027
Table 28: Blood Banks (End-Use) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027
Table 29: Blood Banks (End-Use) Retrospective Demand Analysis
in US$ Million by Region/Country: 2012-2019
Table 30: Blood Banks (End-Use) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
Table 31: Hospitals (End-Use) Demand Potential Worldwide in US$
Million by Region/Country: 2020-2027
Table 32: Hospitals (End-Use) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019
Table 33: Hospitals (End-Use) Share Breakdown Review by
Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Blood Screening Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 34: Blood Screening Market in US$ Million in the United
States by Technology: 2020-2027
Table 35: United States Blood Screening Market Retrospective
Analysis in US$ Million by Technology: 2012-2019
Table 36: United States Blood Screening Market Share Breakdown
by Technology: 2012 VS 2020 VS 2027
Table 37: United States Blood Screening Market Estimates and
Projections in US$ Million by Product & Service: 2020 to 2027
Table 38: Blood Screening Market in the United States by
Product & Service: A Historic Review in US$ Million for
2012-2019
Table 39: United States Blood Screening Market Share Breakdown
by Product & Service: 2012 VS 2020 VS 2027
Table 40: United States Blood Screening Latent Demand Forecasts
in US$ Million by End-Use: 2020 to 2027
Table 41: Blood Screening Historic Demand Patterns in the
United States by End-Use in US$ Million for 2012-2019
Table 42: Blood Screening Market Share Breakdown in the United
States by End-Use: 2012 VS 2020 VS 2027
CANADA
Table 43: Blood Screening Market Analysis in Canada in US$
Million by Technology: 2020-2027
Table 44: Blood Screening Market in Canada: Historic Review in
US$ Million by Technology for the Period 2012-2019
Table 45: Canadian Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 46: Canadian Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020 to 2027
Table 47: Canadian Blood Screening Historic Market Review by
Product & Service in US$ Million: 2012-2019
Table 48: Blood Screening Market in Canada: Percentage Share
Breakdown of Sales by Product & Service for 2012, 2020, and
2027
Table 49: Canadian Blood Screening Market Quantitative Demand
Analysis in US$ Million by End-Use: 2020 to 2027
Table 50: Blood Screening Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by End-Use for
2012-2019
Table 51: Canadian Blood Screening Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
JAPAN
Table 52: Japanese Medium & Long-Term Outlook for Blood
Screening Market in US$ Million by Technology: 2020-2027
Table 53: Blood Screening Market in Japan in US$ Million by
Technology: 2012-2019
Table 54: Japanese Blood Screening Market Percentage Share
Distribution by Technology: 2012 VS 2020 VS 2027
Table 55: Japanese Market for Blood Screening: Annual Sales
Estimates and Projections in US$ Million by Product & Service
for the Period 2020-2027
Table 56: Blood Screening Market in Japan: Historic Sales
Analysis in US$ Million by Product & Service for the Period
2012-2019
Table 57: Japanese Blood Screening Market Share Analysis by
Product & Service: 2012 VS 2020 VS 2027
Table 58: Japanese Demand Estimates and Forecasts for Blood
Screening in US$ Million by End-Use: 2020 to 2027
Table 59: Japanese Blood Screening Market in US$ Million by
End-Use: 2012-2019
Table 60: Blood Screening Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027
CHINA
Table 61: Blood Screening Market Estimates and Forecasts in
China in US$ Million by Technology: 2020-2027
Table 62: Chinese Blood Screening Retrospective Market Scenario
in US$ Million by Technology: 2012-2019
Table 63: Blood Screening Market in China: Percentage Share
Analysis by Technology for 2012, 2020, and 2027
Table 64: Chinese Blood Screening Market Growth Prospects in
US$ Million by Product & Service for the Period 2020-2027
Table 65: Blood Screening Historic Market Analysis in China in
US$ Million by Product & Service: 2012-2019
Table 66: Chinese Blood Screening Market by Product & Service:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 67: Chinese Demand for Blood Screening in US$ Million by
End-Use: 2020 to 2027
Table 68: Blood Screening Market Review in China in US$ Million
by End-Use: 2012-2019
Table 69: Chinese Blood Screening Market Share Breakdown by
End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Blood Screening Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 70: European Blood Screening Market Demand Scenario in
US$ Million by Region/Country: 2020-2027
Table 71: Blood Screening Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2012-2019
Table 72: European Blood Screening Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027
Table 73: European Blood Screening Market Assessment in US$
Million by Technology: 2020-2027
Table 74: European Blood Screening Historic Market Review in
US$ Million by Technology: 2012-2019
Table 75: Blood Screening Market in Europe: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027
Table 76: European Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020-2027
Table 77: Blood Screening Market in Europe in US$ Million by
Product & Service: A Historic Review for the Period 2012-2019
Table 78: European Blood Screening Market Share Breakdown by
Product & Service: 2012 VS 2020 VS 2027
Table 79: European Blood Screening Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 80: Blood Screening Market in Europe: Summarization of
Historic Demand in US$ Million by End-Use for the Period
2012-2019
Table 81: European Blood Screening Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
FRANCE
Table 82: French Blood Screening Market Estimates and
Projections in US$ Million by Technology: 2020-2027
Table 83: French Blood Screening Historic Market Analysis in
US$ Million by Technology: 2012-2019
Table 84: French Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 85: Blood Screening Market in France by Product &
Service: Estimates and Projections in US$ Million for the
Period 2020-2027
Table 86: French Blood Screening Historic Market Scenario in
US$ Million by Product & Service: 2012-2019
Table 87: French Blood Screening Market Share Analysis by
Product & Service: 2012 VS 2020 VS 2027
Table 88: Blood Screening Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027
Table 89: French Blood Screening Historic Market Review in US$
Million by End-Use: 2012-2019
Table 90: French Blood Screening Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
Table 91: German Blood Screening Latent Demand Forecasts in US$
Million by Technology: 2020-2027
Table 92: Blood Screening Market in Germany: A Historic
Perspective by Technology in US$ Million for the Period
2012-2019
Table 93: German Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 94: Blood Screening Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Product & Service
for the Period 2020-2027
Table 95: German Blood Screening Historic Market Analysis in
US$ Million by Product & Service: 2012-2019
Table 96: German Blood Screening Market Share Breakdown by
Product & Service: 2012 VS 2020 VS 2027
Table 97: Blood Screening Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 98: German Blood Screening Market in Retrospect in US$
Million by End-Use: 2012-2019
Table 99: Blood Screening Market Share Distribution in Germany
by End-Use: 2012 VS 2020 VS 2027
ITALY
Table 100: Blood Screening Market Estimates and Forecasts in
Italy in US$ Million by Technology: 2020-2027
Table 101: Italian Blood Screening Retrospective Market
Scenario in US$ Million by Technology: 2012-2019
Table 102: Blood Screening Market in Italy: Percentage Share
Analysis by Technology for 2012, 2020, and 2027
Table 103: Italian Blood Screening Market Growth Prospects in
US$ Million by Product & Service for the Period 2020-2027
Table 104: Blood Screening Historic Market Analysis in Italy in
US$ Million by Product & Service: 2012-2019
Table 105: Italian Blood Screening Market by Product & Service:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 106: Italian Demand for Blood Screening in US$ Million by
End-Use: 2020 to 2027
Table 107: Blood Screening Market Review in Italy in US$
Million by End-Use: 2012-2019
Table 108: Italian Blood Screening Market Share Breakdown by
End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 109: United Kingdom Medium & Long-Term Outlook for Blood
Screening Market in US$ Million by Technology: 2020-2027
Table 110: Blood Screening Market in the United Kingdom in US$
Million by Technology: 2012-2019
Table 111: United Kingdom Blood Screening Market Percentage
Share Distribution by Technology: 2012 VS 2020 VS 2027
Table 112: United Kingdom Market for Blood Screening: Annual
Sales Estimates and Projections in US$ Million by Product &
Service for the Period 2020-2027
Table 113: Blood Screening Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Product & Service for
the Period 2012-2019
Table 114: United Kingdom Blood Screening Market Share Analysis
by Product & Service: 2012 VS 2020 VS 2027
Table 115: United Kingdom Demand Estimates and Forecasts for
Blood Screening in US$ Million by End-Use: 2020 to 2027
Table 116: United Kingdom Blood Screening Market in US$ Million
by End-Use: 2012-2019
Table 117: Blood Screening Market Share Shift in the United
Kingdom by End-Use: 2012 VS 2020 VS 2027
SPAIN
Table 118: Blood Screening Market Analysis in Spain in US$
Million by Technology: 2020-2027
Table 119: Blood Screening Market in Spain: Historic Review in
US$ Million by Technology for the Period 2012-2019
Table 120: Spanish Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 121: Spanish Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020 to 2027
Table 122: Spanish Blood Screening Historic Market Review by
Product & Service in US$ Million: 2012-2019
Table 123: Blood Screening Market in Spain: Percentage Share
Breakdown of Sales by Product & Service for 2012, 2020, and
2027
Table 124: Spanish Blood Screening Market Quantitative Demand
Analysis in US$ Million by End-Use: 2020 to 2027
Table 125: Blood Screening Market in Spain: Summarization of
Historic Demand Patterns in US$ Million by End-Use for
2012-2019
Table 126: Spanish Blood Screening Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
RUSSIA
Table 127: Blood Screening Market in US$ Million in Russia by
Technology: 2020-2027
Table 128: Russian Blood Screening Market Retrospective
Analysis in US$ Million by Technology: 2012-2019
Table 129: Russian Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 130: Russian Blood Screening Market Estimates and
Projections in US$ Million by Product & Service: 2020 to 2027
Table 131: Blood Screening Market in Russia by Product &
Service: A Historic Review in US$ Million for 2012-2019
Table 132: Russian Blood Screening Market Share Breakdown by
Product & Service: 2012 VS 2020 VS 2027
Table 133: Russian Blood Screening Latent Demand Forecasts in
US$ Million by End-Use: 2020 to 2027
Table 134: Blood Screening Historic Demand Patterns in Russia
by End-Use in US$ Million for 2012-2019
Table 135: Blood Screening Market Share Breakdown in Russia by
End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 136: Rest of Europe Blood Screening Market Assessment in
US$ Million by Technology: 2020-2027
Table 137: Rest of Europe Blood Screening Historic Market
Review in US$ Million by Technology: 2012-2019
Table 138: Blood Screening Market in Rest of Europe: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027
Table 139: Rest of Europe Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020-2027
Table 140: Blood Screening Market in Rest of Europe in US$
Million by Product & Service: A Historic Review for the Period
2012-2019
Table 141: Rest of Europe Blood Screening Market Share
Breakdown by Product & Service: 2012 VS 2020 VS 2027
Table 142: Rest of Europe Blood Screening Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 143: Blood Screening Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 144: Rest of Europe Blood Screening Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 145: Asia-Pacific Blood Screening Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 146: Blood Screening Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2012-2019
Table 147: Asia-Pacific Blood Screening Market Share Analysis
by Region/Country: 2012 VS 2020 VS 2027
Table 148: Asia-Pacific Blood Screening Market Estimates and
Projections in US$ Million by Technology: 2020-2027
Table 149: Asia-Pacific Blood Screening Historic Market
Analysis in US$ Million by Technology: 2012-2019
Table 150: Asia-Pacific Blood Screening Historic Market
Analysis in US$ Million by Technology: 2012 VS 2020 VS 2027
Table 151: Blood Screening Market in Asia-Pacific by Product &
Service: Estimates and Projections in US$ Million for the
Period 2020-2027
Table 152: Asia-Pacific Blood Screening Historic Market
Scenario in US$ Million by Product & Service: 2012-2019
Table 153: Asia-Pacific Blood Screening Market Share Analysis
by Product & Service: 2012 VS 2020 VS 2027
Table 154: Blood Screening Quantitative Demand Analysis in
Asia-Pacific in US$ Million by End-Use: 2020-2027
Table 155: Asia-Pacific Blood Screening Historic Market Review
in US$ Million by End-Use: 2012-2019
Table 156: Asia-Pacific Blood Screening Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
AUSTRALIA
Table 157: Australian Blood Screening Latent Demand Forecasts
in US$ Million by Technology: 2020-2027
Table 158: Blood Screening Market in Australia: A Historic
Perspective by Technology in US$ Million for the Period
2012-2019
Table 159: Australian Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 160: Blood Screening Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Product & Service
for the Period 2020-2027
Table 161: Australian Blood Screening Historic Market Analysis
in US$ Million by Product & Service: 2012-2019
Table 162: Australian Blood Screening Market Share Breakdown by
Product & Service: 2012 VS 2020 VS 2027
Table 163: Blood Screening Market in Australia: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 164: Australian Blood Screening Market in Retrospect in
US$ Million by End-Use: 2012-2019
Table 165: Blood Screening Market Share Distribution in
Australia by End-Use: 2012 VS 2020 VS 2027
INDIA
Table 166: Blood Screening Market Analysis in India in US$
Million by Technology: 2020-2027
Table 167: Blood Screening Market in India: Historic Review in
US$ Million by Technology for the Period 2012-2019
Table 168: Indian Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 169: Indian Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020 to 2027
Table 170: Indian Blood Screening Historic Market Review by
Product & Service in US$ Million: 2012-2019
Table 171: Blood Screening Market in India: Percentage Share
Breakdown of Sales by Product & Service for 2012, 2020, and
2027
Table 172: Indian Blood Screening Market Quantitative Demand
Analysis in US$ Million by End-Use: 2020 to 2027
Table 173: Blood Screening Market in India: Summarization of
Historic Demand Patterns in US$ Million by End-Use for
2012-2019
Table 174: Indian Blood Screening Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
SOUTH KOREA
Table 175: Blood Screening Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Technology for
the Period 2020-2027
Table 176: South Korean Blood Screening Historic Market
Analysis in US$ Million by Technology: 2012-2019
Table 177: Blood Screening Market Share Distribution in South
Korea by Technology: 2012 VS 2020 VS 2027
Table 178: Blood Screening Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Product & Service
for the Period 2020-2027
Table 179: South Korean Blood Screening Historic Market
Analysis in US$ Million by Product & Service: 2012-2019
Table 180: Blood Screening Market Share Distribution in South
Korea by Product & Service: 2012 VS 2020 VS 2027
Table 181: Blood Screening Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by End-Use for the
Period 2020-2027
Table 182: South Korean Blood Screening Historic Market
Analysis in US$ Million by End-Use: 2012-2019
Table 183: Blood Screening Market Share Distribution in South
Korea by End-Use: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
Table 184: Rest of Asia-Pacific Medium & Long-Term Outlook for
Blood Screening Market in US$ Million by Technology: 2020-2027
Table 185: Blood Screening Market in Rest of Asia-Pacific in
US$ Million by Technology: 2012-2019
Table 186: Rest of Asia-Pacific Blood Screening Market
Percentage Share Distribution by Technology: 2012 VS 2020 VS
2027
Table 187: Rest of Asia-Pacific Market for Blood Screening:
Annual Sales Estimates and Projections in US$ Million by
Product & Service for the Period 2020-2027
Table 188: Blood Screening Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Product & Service for
the Period 2012-2019
Table 189: Rest of Asia-Pacific Blood Screening Market Share
Analysis by Product & Service: 2012 VS 2020 VS 2027
Table 190: Rest of Asia-Pacific Demand Estimates and Forecasts
for Blood Screening in US$ Million by End-Use: 2020 to 2027
Table 191: Rest of Asia-Pacific Blood Screening Market in US$
Million by End-Use: 2012-2019
Table 192: Blood Screening Market Share Shift in Rest of
Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
LATIN AMERICA
Table 193: Latin American Blood Screening Market Trends by
Region/Country in US$ Million: 2020-2027
Table 194: Blood Screening Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2012-2019
Table 195: Latin American Blood Screening Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027
Table 196: Blood Screening Market Estimates and Forecasts in
Latin America in US$ Million by Technology: 2020-2027
Table 197: Latin American Blood Screening Retrospective Market
Scenario in US$ Million by Technology: 2012-2019
Table 198: Blood Screening Market in Latin America : Percentage
Analysis by Technology for 2012, 2020, and 2027
Table 199: Latin American Blood Screening Market Growth
Prospects in US$ Million by Product & Service for the Period
2020-2027
Table 200: Blood Screening Historic Market Analysis in Latin
America in US$ Million by Product & Service: 2012-2019
Table 201: Latin American Blood Screening Market by Product &
Service: Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 202: Latin American Demand for Blood Screening in US$
Million by End-Use: 2020 to 2027
Table 203: Blood Screening Market Review in Latin America in
US$ Million by End-Use: 2012-2019
Table 204: Latin American Blood Screening Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
ARGENTINA
Table 205: Argentinean Blood Screening Market Assessment in US$
Million by Technology: 2020-2027
Table 206: Argentinean Blood Screening Historic Market Review
in US$ Million by Technology: 2012-2019
Table 207: Blood Screening Market in Argentina: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027
Table 208: Argentinean Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020-2027
Table 209: Blood Screening Market in Argentina in US$ Million
by Product & Service: A Historic Review for the Period
2012-2019
Table 210: Argentinean Blood Screening Market Share Breakdown
by Product & Service: 2012 VS 2020 VS 2027
Table 211: Argentinean Blood Screening Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 212: Blood Screening Market in Argentina: Summarization
of Historic Demand in US$ Million by End-Use for the Period
2012-2019
Table 213: Argentinean Blood Screening Market Share Analysis by
End-Use: 2012 VS 2020 VS 2027
BRAZIL
Table 214: Brazilian Blood Screening Market Estimates and
Projections in US$ Million by Technology: 2020-2027
Table 215: Brazilian Blood Screening Historic Market Analysis
in US$ Million by Technology: 2012-2019
Table 216: Brazilian Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 217: Blood Screening Market in Brazil by Product &
Service: Estimates and Projections in US$ Million for the
Period 2020-2027
Table 218: Brazilian Blood Screening Historic Market Scenario
in US$ Million by Product & Service: 2012-2019
Table 219: Brazilian Blood Screening Market Share Analysis by
Product & Service: 2012 VS 2020 VS 2027
Table 220: Blood Screening Quantitative Demand Analysis in
Brazil in US$ Million by End-Use: 2020-2027
Table 221: Brazilian Blood Screening Historic Market Review in
US$ Million by End-Use: 2012-2019
Table 222: Brazilian Blood Screening Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
MEXICO
Table 223: Mexican Blood Screening Latent Demand Forecasts in
US$ Million by Technology: 2020-2027
Table 224: Blood Screening Market in Mexico: A Historic
Perspective by Technology in US$ Million for the Period
2012-2019
Table 225: Mexican Blood Screening Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 226: Blood Screening Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Product & Service
for the Period 2020-2027
Table 227: Mexican Blood Screening Historic Market Analysis in
US$ Million by Product & Service: 2012-2019
Table 228: Mexican Blood Screening Market Share Breakdown by
Product & Service: 2012 VS 2020 VS 2027
Table 229: Blood Screening Market in Mexico: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 230: Mexican Blood Screening Market in Retrospect in US$
Million by End-Use: 2012-2019
Table 231: Blood Screening Market Share Distribution in Mexico
by End-Use: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
Table 232: Blood Screening Market in US$ Million in Rest of
Latin America by Technology: 2020-2027
Table 233: Rest of Latin America Blood Screening Market
Retrospective Analysis in US$ Million by Technology: 2012-2019
Table 234: Rest of Latin America Blood Screening Market Share
Breakdown by Technology: 2012 VS 2020 VS 2027
Table 235: Rest of Latin America Blood Screening Market
Estimates and Projections in US$ Million by Product & Service:
2020 to 2027
Table 236: Blood Screening Market in Rest of Latin America by
Product & Service: A Historic Review in US$ Million for
2012-2019
Table 237: Rest of Latin America Blood Screening Market Share
Breakdown by Product & Service: 2012 VS 2020 VS 2027
Table 238: Rest of Latin America Blood Screening Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 239: Blood Screening Historic Demand Patterns in Rest of
Latin America by End-Use in US$ Million for 2012-2019
Table 240: Blood Screening Market Share Breakdown in Rest of
Latin America by End-Use: 2012 VS 2020 VS 2027
MIDDLE EAST
Table 241: The Middle East Blood Screening Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 242: Blood Screening Market in the Middle East by
Region/Country in US$ Million: 2012-2019
Table 243: The Middle East Blood Screening Market Share
Breakdown by Region/Country: 2012, 2020, and 2027
Table 244: The Middle East Blood Screening Market Analysis in
US$ Million by Technology: 2020-2027
Table 245: Blood Screening Market in the Middle East: Historic
Review in US$ Million by Technology for the Period 2012-2019
Table 246: The Middle East Blood Screening Market Share
Breakdown by Technology: 2012 VS 2020 VS 2027
Table 247: The Middle East Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020 to 2027
Table 248: The Middle East Blood Screening Historic Market by
Product & Service in US$ Million: 2012-2019
Table 249: Blood Screening Market in the Middle East:
Percentage Share Breakdown of Sales by Product & Service for
2012,2020, and 2027
Table 250: The Middle East Blood Screening Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027
Table 251: Blood Screening Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 252: The Middle East Blood Screening Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
IRAN
Table 253: Iranian Medium & Long-Term Outlook for Blood
Screening Market in US$ Million by Technology: 2020-2027
Table 254: Blood Screening Market in Iran in US$ Million by
Technology: 2012-2019
Table 255: Iranian Blood Screening Market Percentage Share
Distribution by Technology: 2012 VS 2020 VS 2027
Table 256: Iranian Market for Blood Screening: Annual Sales
Estimates and Projections in US$ Million by Product & Service
for the Period 2020-2027
Table 257: Blood Screening Market in Iran: Historic Sales
Analysis in US$ Million by Product & Service for the Period
2012-2019
Table 258: Iranian Blood Screening Market Share Analysis by
Product & Service: 2012 VS 2020 VS 2027
Table 259: Iranian Demand Estimates and Forecasts for Blood
Screening in US$ Million by End-Use: 2020 to 2027
Table 260: Iranian Blood Screening Market in US$ Million by
End-Use: 2012-2019
Table 261: Blood Screening Market Share Shift in Iran by
End-Use: 2012 VS 2020 VS 2027
ISRAEL
Table 262: Israeli Blood Screening Market Assessment in US$
Million by Technology: 2020-2027
Table 263: Israeli Blood Screening Historic Market Review in
US$ Million by Technology: 2012-2019
Table 264: Blood Screening Market in Israel: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027
Table 265: Israeli Blood Screening Market Estimates and
Forecasts in US$ Million by Product & Service: 2020-2027
Table 266: Blood Screening Market in Israel in US$ Million by
Product & Service: A Historic Review for the Period 2012-2019
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798062/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________